Cannara Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is September - August.

Millions USD. Fiscal year is Sep - Aug.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Sep '25 Sep 16, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	Aug '20 Aug 31, 2020	2018 - 2019
Market Capitalization	116	45	67	91	118	54	Upgrade
Market Cap Growth	76.30%	-32.08%	-26.24%	-23.18%	119.59%	-34.84%	Upgrade
Enterprise Value	140	78	97	112	127	57	Upgrade
Last Close Price	1.26	0.54	0.75	1.00	1.30	0.75	Upgrade
PE Ratio	10.31	9.51	13.02	51.35	-	-	Upgrade
PS Ratio	1.57	0.75	1.58	3.30	8.75	27.48	Upgrade
PB Ratio	1.62	0.70	1.13	1.77	2.32	1.83	Upgrade
P/TBV Ratio	1.62	0.70	1.13	1.77	2.32	1.84	Upgrade
P/FCF Ratio	10.68	19.05	-	-	-	-	Upgrade
P/OCF Ratio	7.85	5.73	15.29	-	-	-	Upgrade
EV/Sales Ratio	1.90	1.28	2.29	4.07	9.40	29.09	Upgrade
EV/EBITDA Ratio	7.00	7.62	7.92	16.91	58.11	-	Upgrade
EV/EBIT Ratio	9.04	13.69	11.17	30.25	3041.19	-	Upgrade
EV/FCF Ratio	12.88	32.55	-	-	-	-	Upgrade
Debt / Equity Ratio	0.48	0.55	0.57	0.73	0.33	0.34	Upgrade
Debt / EBITDA Ratio	1.72	3.45	2.75	5.54	7.15	-	Upgrade
Debt / FCF Ratio	3.17	15.04	-	-	-	-	Upgrade
Asset Turnover	0.64	0.55	0.43	0.33	0.23	0.04	Upgrade
Inventory Turnover	1.31	1.41	1.14	1.40	1.39	1.09	Upgrade
Quick Ratio	0.82	0.73	0.70	1.75	1.63	2.32	Upgrade
Current Ratio	2.43	2.50	2.44	3.46	2.82	3.03	Upgrade
Return on Equity (ROE)	17.21%	7.68%	9.48%	3.52%	-2.98%	-29.66%	Upgrade
Return on Assets (ROA)	8.37%	3.23%	5.48%	2.77%	0.04%	-12.16%	Upgrade
Return on Capital (ROIC)	9.65%	3.65%	6.09%	3.01%	0.05%	-13.06%	Upgrade
Return on Capital Employed (ROCE)	15.80%	6.00%	9.70%	4.20%	0.10%	-	Upgrade
Earnings Yield	9.70%	10.52%	7.68%	1.95%	-1.03%	-17.81%	Upgrade
FCF Yield	9.37%	5.25%	-4.39%	-18.20%	-22.26%	-26.41%	Upgrade
Buyback Yield / Dilution	-0.64%	-1.83%	-2.16%	-14.80%	-7.26%	-16.02%	Upgrade

Updated May 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.